Korro Bio, Inc. (KRRO): Free Cash Flow
-$79.08M
Year ended 2025-12-31
-$68.27M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$79.08M | n/m | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | -$77.98M | n/m | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | -$75.12M | n/m | 2025-03-18, From 2023-01-01 |
| 2022-12-31 | -$58.78M | n/c | 2024-03-26, From 2022-01-01 |
| 2021-12-31 | -$78.97M | n/m | 2023-03-10, From 2021-01-01 |
| 2020-12-31 | -$51.86M | n/m | 2022-03-15, From 2020-01-01 |
| 2019-12-31 | $33.15M | n/m | 2021-03-29, From 2019-01-01 |
| 2018-12-31 | -$17.46M | n/m | 2020-03-26, From 2018-01-01 |
| 2017-12-31 | -$16.48M | n/a | 2020-03-26, From 2017-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | 2025-12-31 | -$79.08M | n/m |
| Immunome Inc. (IMNM) | 2025-12-31 | -$200.60M | n/m |
| Whitehawk Therapeutics, Inc. (WHWK) | 2025-12-31 | -$97.98M | n/m |
| Ovid Therapeutics Inc. (OVID) | 2025-12-31 | -$38.33M | n/m |
| Xenon Pharmaceuticals Inc. (XENE) | 2025-12-31 | -$279.92M | n/m |
| Adagene Inc. (ADAG) | 2025-12-31 | -$15.67M | n/m |
| Bolt Biotherapeutics, Inc. (BOLT) | 2025-12-31 | -$39.92M | n/m |
| Aclaris Therapeutics, Inc. (ACRS) | 2025-12-31 | -$47.22M | n/m |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | -$7.93M | n/a |
Compare KRRO, IMNM, WHWK, OVID side by side · Screen every company in Pharmaceutical Preparations ↗